GFAP and Alexander disease: Given the deleterious consequences of GFAP overexpression in AxD, a research group from the Waisman Center at the University of Wisconsin-Madison applied intracerebroventricular (ICV) bolus injection of an antisense oligonucleotide (ASO) targeting Gfap transcript in Gfap+/R236H mice.